Introduction In daily practice management of psoriasis, evaluation of risk factors for infections is having a growing influence. Indeed, in psoriatic patients, risk of infections may be due to psoriasis itself, immunomodulatory therapy, and comorbidities that may increase this risk and patient hospitalization. Areas covered Given the greater understanding of psoriasis pathogenesis and the increasing number of treatment options, it is particularly important to customize therapy according to each, single patient; psoriasis features and comorbidities are also essential to tailor treatment goals. Expert opinion In this perspective, the current knowledge on the infectious risk in psoriatic patient, related to comorbidities, such as diabetes mellitus, cardiovascular disease, and chronic obstructive pulmonary, to 'special populations,' to chronic infections, such as latent tuberculosis, chronic hepatitis B and C, and HIV, and to the most recent Covid-19 pandemic scenario, is reviewed and discussed in order to suggest the most appropriate approach and achieve the best available therapeutic option.

De Simone, C., Fargnoli, M.c., Amerio, P., Bianchi, L., Esposito, M., Pirro, F., et al. (2021). Risk of infections in psoriasis: assessment and challenges in daily management. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 17(11), 1211-1220 [10.1080/1744666X.2021.1997592].

Risk of infections in psoriasis: assessment and challenges in daily management

Bianchi, Luca;
2021

Abstract

Introduction In daily practice management of psoriasis, evaluation of risk factors for infections is having a growing influence. Indeed, in psoriatic patients, risk of infections may be due to psoriasis itself, immunomodulatory therapy, and comorbidities that may increase this risk and patient hospitalization. Areas covered Given the greater understanding of psoriasis pathogenesis and the increasing number of treatment options, it is particularly important to customize therapy according to each, single patient; psoriasis features and comorbidities are also essential to tailor treatment goals. Expert opinion In this perspective, the current knowledge on the infectious risk in psoriatic patient, related to comorbidities, such as diabetes mellitus, cardiovascular disease, and chronic obstructive pulmonary, to 'special populations,' to chronic infections, such as latent tuberculosis, chronic hepatitis B and C, and HIV, and to the most recent Covid-19 pandemic scenario, is reviewed and discussed in order to suggest the most appropriate approach and achieve the best available therapeutic option.
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore MED/35
English
Infection
comorbidities
covid-19
management
psoriasis
risk
COVID-19
Cardiovascular Diseases
Comorbidity
Humans
Pandemics
Psoriasis
Risk Assessment
Risk Factors
SARS-CoV-2
Virus Diseases
De Simone, C., Fargnoli, M.c., Amerio, P., Bianchi, L., Esposito, M., Pirro, F., et al. (2021). Risk of infections in psoriasis: assessment and challenges in daily management. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 17(11), 1211-1220 [10.1080/1744666X.2021.1997592].
De Simone, C; Fargnoli, Mc; Amerio, P; Bianchi, L; Esposito, M; Pirro, F; Potenza, C; Ricceri, F; Rongioletti, F; Stingeni, L; Prignano, F
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/304602
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact